Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis

Salman Razvi, Mia Holley, Hannah Wheeler, Jonathan Vernazza, Kathryn Stewart, Simon H.S. Pearce, Kilimangalam Narayanan, Vasileios Tsatlidis

Open source

DOI: 10.1177/10507256261470303
Published: 2026-07-21
Container: Thyroid®
Publisher: SAGE Publications
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/10507256261470303,
  title = {Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis},
  author = {Salman Razvi and Mia Holley and Hannah Wheeler and Jonathan Vernazza and Kathryn Stewart and Simon H.S. Pearce and Kilimangalam Narayanan and Vasileios Tsatlidis},
  year = {2026},
  journal = {Thyroid®},
  doi = {10.1177/10507256261470303},
  url = {https://doi.org/10.1177/10507256261470303}
}

RIS

TY  - JOUR
TI  - Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis
AU  - Salman Razvi
AU  - Mia Holley
AU  - Hannah Wheeler
AU  - Jonathan Vernazza
AU  - Kathryn Stewart
AU  - Simon H.S. Pearce
AU  - Kilimangalam Narayanan
AU  - Vasileios Tsatlidis
PY  - 2026
JO  - Thyroid®
DO  - 10.1177/10507256261470303
UR  - https://doi.org/10.1177/10507256261470303
ER  -

APA

Razvi, S., Holley, M., Wheeler, H., Vernazza, J., Stewart, K., Pearce, S. H., Narayanan, K., & Tsatlidis, V. (2026). Shorter Versus Standard Antithyroid Drug Therapy in Graves’ Disease with Lower Baseline Thyrotropin Receptor Antibody (TRAb) Levels: Relapse Outcomes from a Propensity-Weighted Analysis. Thyroid®. https://doi.org/10.1177/10507256261470303

Source records

crossref · retrieved 2026-09-27T09:23:02.565Z